elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35606384-57C26E3D-261A-47A7-B86B-F7A2C492BCB9
Q35606384-57C26E3D-261A-47A7-B86B-F7A2C492BCB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35606384-57C26E3D-261A-47A7-B86B-F7A2C492BCB9
HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.
P2860
Q35606384-57C26E3D-261A-47A7-B86B-F7A2C492BCB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35606384-57C26E3D-261A-47A7-B86B-F7A2C492BCB9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
69064032bd20bb3fe868feb95fc8a7dd55fa783a
P2860
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.